£148.53

Springer Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 3 months ago.

£149 today · all-time low £148 (Feb 2026) · usually £149

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical
Generating forecast...
£149.64 £148.28 £148.57 £148.87 £149.17 £149.47 £149.76 18 February 2026 12 March 2026 03 April 2026 25 April 2026 18 May 2026

Price Distribution

Price distribution over 90 days • 2 price levels

Days at Price
Current Price
49 days · current 41 days 0 12 25 37 49 £148 £150 Days at Price

Price Analysis

Most common price: £148 (49 days, 54.4%)

Price range: £148 - £150

Price levels: 2 different prices over 90 days

Description

Product Description Where do you begin to look for a recent, authoritative article on the diagnosis or management of a particular malignancy? The few general oncology textbooks are generally out of date. Single papers in specialized journals are informative, but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals frequently publish good in-depth reviews of cancer topics, and published symposium lectures are often the best overviews available. Unfor tunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes that aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, which is revised frequently to keep the coverage up to date, and which is easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion: first, by dividing the oncology literature into specific subdivisions, such as lung can cer, genitourinary cancer, pediatric oncology, etc.; and second, by asking eminent authorities in each of these areas to edit a volume on the specific topic on an annual or biannual basis. Each topic and tumor type is covered in a volume appearing frequently and predictably, discussing current diag nosis, staging, markers, all forms of treatment modalities, basic biology, and more. Review 'I believe that this book will be of considerable interest to all practising oncologist be they surgeons, physicians or radiotherapists and would be a useful addition to their personal library. ' Australian Cancer Society 16:2 1991

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
25 September 2012
Listed Since
06 December 2012

Barcode

No barcode data available

Similar Products You Might Like

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
96% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£163.15 18 May 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
92% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 18 May 2026
Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)
91% match

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)

Springer

£149.64 18 May 2026
Oncologic Therapies
86% match

Oncologic Therapies

Springer

£81.58 18 May 2026
Gynecologic Oncology: Controversies and New Developments: 70 (Cancer Treatment and Research, 70)
84% match

Gynecologic Oncology: Controversies and New Developments: 70 (Cancer Treatment and Research, 70)

Springer

£113.76 18 May 2026
Clinical Management of Soft Tissue Sarcomas: 29 (Cancer Treatment and Research, 29)
84% match

Clinical Management of Soft Tissue Sarcomas: 29 (Cancer Treatment and Research, 29)

Springer

£113.76 18 May 2026
Orthopaedic Oncology: Primary and Metastatic Tumors of the Skeletal System: 162 (Cancer Treatment and Research, 162)
84% match

Orthopaedic Oncology: Primary and Metastatic Tumors of the Skeletal System: 162 (Cancer Treatment and Research, 162)

Springer

£73.10 18 May 2026
Cancer in Children, Second Revised and Enlarge Edition: Clinical Management (UICC Current Treatment of Cancer)
84% match

Cancer in Children, Second Revised and Enlarge Edition: Clinical Management (UICC Current Treatment of Cancer)

Springer

£89.99 17 May 2026
Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)
83% match

Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)

Springer

£77.37 18 May 2026
Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)
83% match

Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)

Springer

£113.94 18 May 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
83% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 17 May 2026
Oncology of CNS Tumors
83% match

Oncology of CNS Tumors

Springer

£179.99 18 May 2026
Cancer Clinical Trials: Proactive Strategies: 132 (Cancer Treatment and Research, 132)
83% match

Cancer Clinical Trials: Proactive Strategies: 132 (Cancer Treatment and Research, 132)

Springer

£107.98 18 May 2026
Bone Sarcoma (MD Anderson Cancer Care Series)
83% match

Bone Sarcoma (MD Anderson Cancer Care Series)

Springer

£73.10 18 May 2026
Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach (Pediatric Oncology)
83% match

Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach (Pediatric Oncology)

Springer

£104.18 17 May 2026
Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)
82% match

Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)

Springer

£149.65 18 May 2026
Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)
82% match

Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)

Springer

£113.76 18 May 2026
Oral Cancer: Diagnosis and Therapy
82% match

Oral Cancer: Diagnosis and Therapy

Springer

£94.43 17 May 2026
Gene-Based Therapies for Cancer (Current Cancer Research)
82% match

Gene-Based Therapies for Cancer (Current Cancer Research)

Springer

£107.50 18 May 2026
New Trends in Cancer for the 21st Century: 587 (Advances in Experimental Medicine and Biology, 587)
82% match

New Trends in Cancer for the 21st Century: 587 (Advances in Experimental Medicine and Biology, 587)

Springer

£147.11 11 May 2026
Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)
82% match

Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)

Springer

£107.85 18 May 2026
The Cancer Patient and Supportive Care: Medical, Surgical, and Human Issues: 25 (Cancer Treatment and Research, 25)
82% match

The Cancer Patient and Supportive Care: Medical, Surgical, and Human Issues: 25 (Cancer Treatment and Research, 25)

Springer

£113.77 18 May 2026
Alternative and Complementary Therapies for Cancer: Integrative Approaches and Discovery of Conventional Drugs
82% match

Alternative and Complementary Therapies for Cancer: Integrative Approaches and Discovery of Conventional Drugs

Springer

£77.90 18 May 2026
Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)
82% match

Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)

Springer

£77.79 11 May 2026